Short term immunosuppressive therapy and long-term immunoregulation: promises and problems.
Open Access
- 1 December 1996
- journal article
- review article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 80 (12), 1035-1036
- https://doi.org/10.1136/bjo.80.12.1035
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- The possible impact of uveitis in blindness: a literature survey.British Journal of Ophthalmology, 1996
- Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retinaEuropean Journal of Immunology, 1996
- Mechanisms of Peripheral Tolerance and Suppression Induced by Monoclonal Antibodies to CD4 and CD8Immunological Reviews, 1996
- Section Review: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: New modes of immunosuppression for the prevention of allograft rejectionExpert Opinion on Investigational Drugs, 1996
- Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.British Journal of Ophthalmology, 1995
- Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1HEye, 1995
- Long-term remission of intractable systemic vasculitis with monoclonal antibody therapyThe Lancet, 1993
- Reprogramming the Immune System for Peripheral Tolerance with CD4 and CD8 Monoclonal AntibodiesImmunological Reviews, 1992
- Low-dose cyclosporin therapy of ocular inflammation: Preliminary report of a long-term follow-up studyJournal of Autoimmunity, 1992
- The induction of skin graft tolerance in major histocompatibility complex‐mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti‐CD4 and anti‐CD8 antibodiesEuropean Journal of Immunology, 1990